REFERENCES

1. Brinsden PR. Thirty years of IVF: the legacy of Patrick Steptoe and Robert Edwards. Hum Fertil (Camb) 2009;12:137-43.

2. Dyer S, Chambers GM, de Mouzon J, et al. International Committee for Monitoring Assisted Reproductive Technologies world re­port: Assisted Reproductive Technology 2008, 2009 and 2010.

3. Franasiak JM, Forman EJ, Hong KH, et al. Aneuploidy across indi­vidual chromosomes at the embryonic level in trophectoderm bi­opsies: changes with patient age and chromosome structure. J Assist Reprod Genet 2014;31:1501-509.

4. Skakkebaek NE, Rajpert-De Meyts E, Buck Louis GM, et al. Male reproductive disorders and fertility trends: influences of environ­ment and genetic susceptibility. Physiol Rev 2016;96:55-97.

5. Dumesic DA, Oberfield SA, Stener-Victorin E, et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysi­ology, and molecular genetics of polycystic ovary syndrome. Endocr Rev 2015;36:487-525.

6. Tobler KJ, Shoham G, Christianson MS, et al. Use of anti- mullerian hormone for testing ovarian reserve: a survey of 796 infertility clinics worldwide. J Assist Reprod Genet 2015;32: 1441-48.

7. Li HW, Lee VC, Lau EY, et al. Role of baseline antral follicle count and anti- mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort ana­lysis. PLoS One 2013;8:e61095.

8. Rutherford AJ, Subak-Sharpe RJ, Dawson KJ, et al. Improvement of in vitro fertilisation after treatment with buserelin, an agonist of luteinising hormone releasing hormone. BrMed J (Clin Res Ed) 1988;296:1765-68.

9. Damewood MD, Shen W, Zacur HA, et al. Disappearance of ex­ogenously administered human chorionic gonadotropin. Fertil Steril 1989;52:398-400.

10. McClure N, Healy DL, Rogers PA, et al. Vascular endothe­lial growth factor as capillary permeability agent in ovarian hyperstimulation syndrome.

11. Seng SW, Ong KJ, Ledger WL. Gonadotropin-releasing hormone antagonist in in vitro fertilization superovulation. Womens Health (Lond) 2006;2:881-88.

12. Fauser BC, de Jong D, Olivennes F, et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab 2002;87:709-15.

13. Devroey P, Polyzos NP, Blockeel C. An OHSS-free clinic by seg­mentation of IVF treatment. Hum Reprod 2011;26:2593-97.

14. Catford SR, McLachlan RI, O’Bryan MK, Halliday JL. Long-term follow-up of intra-cytoplasmic sperm injection-conceived off­spring compared with in vitro fertilization-conceived offspring: a systematic review of health outcomes beyond the neonatal period. Andrology 2017;5:610-21.

15. Wong CC, Loewke KE, Bossert NL et al. Non-invasive im­aging of human embryos before embryonic genome activation predicts development to the blastocyst stage. Nat Biotechnol 2010;28:1115-21.

16. Chambers GM, Wand H, Macaldowie A, et al. Population trends and live birth rates associated with common ART treatment strat­egies. Hum Reprod 2016;31:2632-41.

17. hfeaarchive.uksouth.cloudapp.azure.com/www.hfea.gov.uk/ 10516.html

18. Wong KM, van Wely M, Mol F, Repping S, Mastenbroek S. Fresh versus frozen embryo transfers in assisted reproduction. Cochrane Database Syst Rev 2017;3:CD011184.

19. van der Linden M, Buckingham K, Farquhar C, Kremer JA, Metwally M. Luteal phase support for assisted reproduction cycles. Cochrane Database Syst Rev 2015;7:CD009154.

20. Chambers GM, Paul RC, Harris K, et al. Assisted reproductive technology in Australia and New Zealand: cumulative live birth rates as measures of success. Med J Aust 2017;207:114-18.

21. Sharpe A, Avery P, Choudhary M. Reproductive outcome fol­lowing pre-implantation genetic diagnosis (PGD) in the UK. Hum Fertil (Camb) 2018;21:120-27.

22. Sermon K, Capalbo A, Cohen J, et al. The why, the how and the when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists, and embryologists. Mol Hum Reprod 2016;22:845-57.

23. Mastenbroek S, Twisk M, van Echten-Arends J, et al. In vitro fer­tilization with preimplantation genetic screening. N Engl J Med 2007;357:9-17.

24. Woodruff TK. Oncofertility: a grand collaboration between repro­ductive medicine and oncology. Reproduction 2015;150:S1-10.

25. Ataman LM, Rodrigues JK, Marinho RM, et al. Creating a global community of practice for oncofertility. J Glob Oncol 2016;2:83-96.

26. Birch Petersen K, Hvidman HW, Sylvest R, et al. Family intentions and personal considerations on postponing childbearing in child­less cohabiting and single women aged 35-43 seeking fertility as­sessment and counselling. Hum Reprod 2015;30:2563-74.

27. Nagy ZP, Chang CC, Shapiro DB, et al. Clinical evaluation of the efficiency of an oocyte donation program using egg cryo-banking. Fertil Steril 2009;92:520-26.